全球鉴别诊断市场 – 2029 年行业趋势及预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球鉴别诊断市场 – 2029 年行业趋势及预测

  • Healthcare
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>全球鉴别诊断市场,按治疗类型(胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠问题)、可用性(身体健康障碍、精神健康障碍)、最终用途(医院、诊断中心、其他)划分 - 行业趋势和预测到 2029 年。

鉴别诊断市场

鉴别诊断市场分析和规模

鉴别诊断用于帮助诊断引起类似症状的精神健康或身体健康障碍。诊断过程包括通过评估患者的病史、体格检查和查看实验室数据或诊断影像来识别或确定疾病或病症的病因。尽管鉴别诊断需要所有医疗保健提供者具备不同的技能,但诊断的概念是通用的,无论一个人的背景如何。诊断可以改善分类工具的使用,提高清晰度和沟通能力,提供治疗轨迹,提高对患者预后的理解,并且在某些情况下可能有助于预防性治疗。

Data Bridge Market Research 分析,鉴别诊断市场预计在 2022 年至 2029 年的预测期内实现健康的复合年增长率。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

鉴别诊断市场范围和细分  

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

治疗类型(胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠问题)、可用性(身体健康障碍、精神健康障碍)、最终用途(医院、诊断中心、其他)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

市场参与者

Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), BD (U.S.), Danaher (U.S.), Meridian Bioscience Inc. (U.S.), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics (U.S.), bioMérieux (France), Luminex Corporation (U.S.), Siemens (Germany), SA Scientific, Ltd. (U.S.), ELITech Group (France), Coris Bioconcept SPRL (Belgium)

Market Opportunities

  • Rising healthcare spending
  • Rising number of population suffering from mental illness 

Market Definition

A differential diagnosis is a list of possible conditions or diseases that could be the source of symptoms. It is based on the information gathered from your symptoms, medical history, basic laboratory results, and a physical examination. Differential diagnosis is a process wherein a doctor distinguishes between two or more conditions which could be behind a person's symptoms.

Global Differential Diagnostics Market Dynamics

Drivers

  • Technological developments

Diagnostic technology advancements enabled physicians to evaluate processes and events in real time (in the living body). During the 1970s, advances in computer technology enabled the development of non-invasive technologies that were accurate, accessible, and relatively inexpensive. The clinical application of advances in physics and mathematics resulted in the development of high-tech diagnostic tools. These technological advancements enabled the development of a number of tools that made diagnosis more accurate, less invasive, and less expensive.

  • Rise in diagnostic tests

Diagnostic tests are typically performed in private or public laboratories equipped with appropriate and sometimes expensive instrumentation and staffed with trained and qualified personnel. POC testing, which occurs at or near the site of patient care, is sought after the field of infectious bacterial diagnostics to allow the care team to receive results more quickly and make immediate and informed management decisions.

Opportunities

  • Rise in number of clinics

The otolaryngic allergist must be able to differentiate between common no allergic diagnosis. Clinicians will be able to identify various conditions, which will enhance their ability to appropriately make correct decisions for prompt and efficient management of their patients with allergic or no allergic diseases of the head and neck, so these will propel the market growth.

Restraints/Challenges

  • Longer duration of differential diagnostics

Longer duration of differential diagnosis will obstruct the market's growth rate. Forming a differential diagnosis necessitates additional testing to guide your healthcare provider to the correct diagnosis rather than treating symptoms without understanding the cause. If any step of the diagnostic process is missing, the differential diagnosis may result in an inaccurate diagnosis.

本鉴别诊断市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关鉴别诊断市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球鉴别诊断市场范围

鉴别诊断市场根据治疗类型、可用性和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

治疗类型

  • 胸痛
  • 头痛
  • 发烧
  • 肺炎
  • 高血压
  • 疲劳
  • 睡眠问题

 可用性

  • 身体健康障碍
  • 精神健康障碍

最终用途

  • 医院
  • 诊断中心
  • 其他的

鉴别诊断市场区域分析/见解

对鉴别诊断市场进行了分析,并按国家、治疗类型、可用性和最终用途提供了市场规模洞察和趋势,如上所述。

鉴别诊断市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美由于其拥有完善的诊断基础设施、技术进步以及患者意识的不断增强而主导着鉴别诊断市场。

由于亚太地区的创新和跨学科技术和产品的不断增长,预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和鉴别诊断市场份额分析

鉴别诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对鉴别诊断市场的关注有关。

鉴别诊断市场的一些主要参与者包括:

  • 赛默飞世尔科技公司(美国)
  • Hologic, Inc.(美国)
  • Quidel Corporation(美国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • 雅培(美国)
  • BD(美国)
  • 丹纳赫(美国)
  • Meridian Bioscience Inc.(美国)
  • GenMark Diagnostics, Inc.(美国)
  • Sekisui Diagnostics(美国)
  • 生物梅里埃(法国)
  • Luminex 公司(美国)
  • 西门子(德国)
  • SA Scientific, Ltd.(美国)
  • ELITech集团(法国)
  • Coris Bioconcept SPRL(比利时)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Factors such as rising number of population suffering from mental illness are the major growth driving factors.
Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), BD (U.S.), Danaher (U.S.), Meridian Bioscience Inc. (U.S.), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics (U.S.), bioMérieux (France), Luminex Corporation (U.S.), Siemens (Germany), SA Scientific, Ltd. (U.S.), ELITech Group (France), Coris Bioconcept SPRL (Belgium) are the major companies operating in this market.